Naloxone Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Naloxone Side Effects
Did You Have Naloxone Side Effect? |
Naloxone Side Effects Poll Results | ||||||||
|
Vote Below:
|
Have you experienced Naloxone side effects?
|
100%Naloxone Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Naloxone:
What is Your Question? Ask Community:
Daily Health Videos
Naloxone Side Effects reported on Patientsville.com
None reported at this time.Naloxone Side Effects reported to FDA
Naloxone Side Effects Report #5783148-9
Consumer or non-health professional from DENMARK reported Naloxone side effect on June 03, 2008. Female patient, 62 years of age, was diagnosed with sedation and was treated with Naloxone. After drug was administered, patient experienced the following side effects: diplopia, embolism, eye pain, hypertensive crisis, injury, neck pain, vision blurred, visual field defect. Naloxone dosage: unknown. During the same period patient was treated with OXYCONTIN, MIDAZOLAM, GABAPENTIN, FENTANYL. Patient recovered.
Naloxone Side Effects Report #5813600-9
Naloxone side effect was reported by a Pharmacist from UNITED STATES on July 16, 2008. Male patient, 51 years of age, was treated with Naloxone. After drug was administered, patient experienced the following side effects: hypotension, respiratory disorder, tremor. Naloxone dosage: unknown. Patient was hospitalized. Patient recovered.
Naloxone Side Effects Report #5849300-9
Physician from UNITED STATES reported Naloxone side effect on Aug 04, 2008. Female patient, 57 years of age, weighting 121.3 lb, was diagnosed with overdose and was treated with Naloxone. After drug was administered, patient experienced the following side effects: foaming at mouth, loss of consciousness, miosis, neuroleptic malignant syndrome. Naloxone dosage: 0.4 MG, 3 DOSES, INTRAVENOUS. During the same period patient was treated with FENTANYL, LAMOTRIGINE, OXYCODONE, BUPROPION, DULOXETINE. Patient was hospitalized. Patient recovered.
Naloxone Side Effects Report #6038058-9
Naloxone side effect was reported by a Pharmacist from UNITED STATES on Jan 13, 2009. Female patient, 73 years of age, was diagnosed with somnolence and was treated with Naloxone. After drug was administered, patient experienced the following side effects: flushing, somnolence. Naloxone dosage: 0.4MG ONCE IV. Patient recovered.
Naloxone Side Effects Report #4690064-2
Physician from reported Naloxone side effect on June 03, 2005. Female patient was diagnosed with overdose and was treated with Naloxone. After drug was administered, patient experienced the following side effects: confusional state, feeling abnormal, loss of consciousness, miosis, overdose, respiratory failure, tremor. Naloxone dosage: 0.4 MG PRN IM/IV. Patient was hospitalized. Patient recovered.
Naloxone Side Effects Report #4690065-4
Naloxone side effect was reported by a Consumer or non-health professional from on June 03, 2005. Female patient was diagnosed with overdose and was treated with Naloxone. After drug was administered, patient experienced the following side effects: confusional state, headache
, visual disturbance. Naloxone dosage: 0.4 MG PRN IM/IV. Patient was hospitalized. Patient recovered.Naloxone Side Effects Report #4692022-0
Physician from reported Naloxone side effect on June 03, 2005. Male patient, 23 years of age, was treated with Naloxone. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, hypoxia, loss of consciousness, phlebothrombosis, pneumonia aspiration, pulmonary toxicity. Naloxone dosage: unknown. Patient was hospitalized. Patient recovered.
Naloxone Side Effects Report #4703407-8
Naloxone side effect was reported by a Physician from on June 16, 2005. Female patient, weighting 4.48 lb, was treated with Naloxone. After drug was administered, patient experienced the following side effects: cerebral ventricle dilatation, congenital anomaly, microcephaly, porencephaly. Naloxone dosage: 0.4 MG 2 DOSES T-PLAC. During the same period patient was treated with METHADONE, DIAZEPAM. Patient recovered.
Naloxone Side Effects Report #4726979-6
Pharmacist from UNITED STATES reported Naloxone side effect on July 26, 2005. Male patient, 65 years of age, was diagnosed with reversal of opiate activity, back pain
and was treated with Naloxone. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness, mental status changes, overdose. Naloxone dosage: 0.8MG IV ONCE. During the same period patient was treated with MS CONTIN, ALLOPURINOL, TYLENOL NO, TERAZOSIN, MORPHINE, CELEXA, REMERON, ZYPREXA. Patient was hospitalized. Patient recovered.Naloxone Side Effects Report #4732561-7
Naloxone side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2005. Male patient, 45 years of age, weighting 128.1 lb, was treated with Naloxone. After drug was administered, patient experienced the following side effects: convulsion. Naloxone dosage: unknown. Patient recovered.
Naloxone Side Effects Report #4852820-7
Pharmacist from UNITED STATES reported Naloxone side effect on Dec 12, 2005. Male patient, 82 years of age, weighting 224.4 lb, was diagnosed with reversal of opiate activity, sedation and was treated with Naloxone. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea, nausea
, retching, throat tightness. Naloxone dosage: 0.4 MG ONCE IV. Patient recovered.Naloxone Side Effects Report #4895110-9
Naloxone side effect was reported by a Consumer or non-health professional from NORWAY on Jan 17, 2006. Male patient, 25 years of age, was diagnosed with overdose and was treated with Naloxone. After drug was administered, patient experienced the following side effects: confusional state, headache
, loss of consciousness, miosis, overdose, respiratory failure, restlessness. Naloxone dosage: 0.8 MG ONCE IM. During the same period patient was treated with HEROIN, ROHYPNOL. Patient was hospitalized. Patient recovered.Naloxone Side Effects Report #4895113-4
Consumer or non-health professional from NORWAY reported Naloxone side effect on Jan 17, 2006. Male patient, 25 years of age, was diagnosed with overdose and was treated with Naloxone. After drug was administered, patient experienced the following side effects: confusional state, feeling abnormal, loss of consciousness, miosis, respiratory arrest, respiratory failure, tremor. Naloxone dosage: 0.8 MG 2 DOSES IM/IV. During the same period patient was treated with HEROIN, ROHYPNOL, ALCOHOL. Patient was hospitalized. Patient recovered.
Naloxone Side Effects Report #4960366-0
Naloxone side effect was reported by a Health Professional from GERMANY on Mar 14, 2006. Male patient, 56 years of age, weighting 235.9 lb, was diagnosed with back pain
and was treated with Naloxone. After drug was administered, patient experienced the following side effects: gastroenteritis . Naloxone dosage: 20 MG, BID, ORAL. During the same period patient was treated with TORSEMIDE, RAMIPRIL, BISOPROLOL FUMARATE, SIMVASTATIN, CITALOPRAM, DOLO POSTERINE, POSTERISANTE. Patient was hospitalized. Patient recovered.Naloxone Side Effects Report #4985297-1
Physician from UNITED STATES reported Naloxone side effect on Dec 09, 2005. Male patient, 67 years of age, weighting 273.4 lb, was diagnosed with back pain
, pain in extremity, hypertension, diabetes mellitus and was treated with Naloxone. After drug was administered, patient experienced the following side effects: blood glucose increased, cerebrovascular accident, sinus tachycardia. Naloxone dosage: unknown. During the same period patient was treated with VIOXX, MONOPRIL, TRIMOX, BIAXIN, METFORMIN, HYDROCODONE BITARTRATE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Advise and Guidance
Headache and What makes your head hurt?
Injury and Fda requires new safety measures for oral sodium phosphate products to reduce ri